New issue: WHO Guideline on Use of GLP-1s for Obesity, Review on Gastric Cancer, Metformin Use in PAD, and more

Back to news list

Source: Email Newsletter

Original: email://618...

Published: Tue, 3 Feb 2026 15:26:43 -0600 (CST)

The new edition includes a World Health Organization (WHO) guideline on the use of glucagon-like peptide-1 (GLP-1) therapies to treat obesity in adults. It also includes an overview of stomach cancer. Also included is original research on the use of metformin to improve walking performance in patients with peripheral artery disease (PAD). A podcast is also available for the WHO guideline on GLP-1.